Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04648904 · ClinicalTrials.gov registry record · Early Phase 1
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
A Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT04648904: Active Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04648904 is a Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 71 participants, below the 129-participant average among 19 other Invasive Breast Cancer trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04648904, a Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see whether providing radiation on a shortened (compressed) schedule of 5 days in a row is a safe and effective approach to prevent cancer from coming back in people who have had a mastectomy.
Primary Outcome
Local recurrence is defined as histologic evidence of ductal carcinoma in situ or invasive breast cancer in the ipsilateral reconstructed breast or chest wall.
Conditions Studied
Interventions
- RADIATION Radiotherapy
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2026-11 |
| Phase | Early Phase 1 |
What the registry record for NCT04648904 still lists
NCT04648904 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 129-participant average among 19 other Invasive Breast Cancer trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with Invasive Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiotherapy is the first listed.
NCT04648904 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04648904 about?
NCT04648904 is a clinical study titled "Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer". The purpose of this study is to see whether providing radiation on a shortened (compressed) schedule of 5 days in a row is a safe and effective approach to prevent cancer from coming back in people who have had a mastectomy.
What is the current status of trial NCT04648904?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 71 participants. The study started on 2020-11-24. Estimated completion is 2026-11.
What conditions does trial NCT04648904 study?
This clinical trial studies the following conditions: Invasive Breast Cancer, Post-mastectomy.
What interventions are being tested in trial NCT04648904?
The interventions under investigation include: Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT04648904?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04648904 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Invasive Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04648904's enrollment target sits among peer trials
71 11th of 19 higher than 9 of 19 other Invasive Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Invasive Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
TRUDI: TDXD+Durva in HER2+/Low IBC
RECRUITING · Phase 2
-
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
RECRUITING · Phase 1
-
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
RECRUITING · Phase 2
-
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI